当前位置:首页 - 行情中心 - 大禹生物(920970) - 财务分析 - 现金流量表

大禹生物

(920970)

  

流通市值:4.98亿  总市值:7.87亿
流通股本:7007.13万   总股本:1.11亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金34,805,204.18180,988,932.16101,025,789.6364,977,008.22
  收到的税费返还1,485.48---
  收到其他与经营活动有关的现金538,243.217,219,315.6716,115,668.0515,140,572.88
  经营活动现金流入小计35,344,932.86198,208,247.83117,141,457.6880,117,581.1
  购买商品、接受劳务支付的现金42,965,024.74141,589,702.0294,516,476.752,519,285.4
  支付给职工以及为职工支付的现金8,702,606.9229,977,596.2422,775,209.1115,404,968.3
  支付的各项税费537,197.287,338,437.665,161,124.553,186,701.61
  支付其他与经营活动有关的现金1,758,209.99,121,147.578,360,998.325,376,273.26
  经营活动现金流出小计53,963,038.84188,026,883.49130,813,808.6876,487,228.57
  经营活动产生的现金流量净额-18,618,105.9810,181,364.34-13,672,3513,630,352.53
二、投资活动产生的现金流量:
  收回投资收到的现金---8,020-8,020
  收到的其他与投资活动有关的现金--276,554.82276,554.82
  投资活动现金流入的平衡项目--00
  投资活动现金流入小计--268,534.82268,534.82
  购建固定资产、无形资产和其他长期资产支付的现金17,328,927.7143,027,308.0329,199,023.9310,566,307.66
  投资支付的现金-8,216.72196.72196.72
  支付其他与投资活动有关的现金--276,554.82276,554.82
  投资活动现金流出小计17,328,927.7143,035,524.7529,475,775.4710,843,059.2
  投资活动产生的现金流量净额-17,328,927.71-43,035,524.75-29,207,240.65-10,574,524.38
三、筹资活动产生的现金流量:
  取得借款收到的现金50,400,000107,900,00092,900,00058,400,000
  筹资活动现金流入小计50,400,000107,900,00092,900,00058,400,000
  偿还债务支付的现金14,475,00066,475,00050,875,00029,400,000
  分配股利、利润或偿付利息支付的现金1,028,918.413,048,488.472,132,022.971,317,914.47
  支付其他与筹资活动有关的现金211,242797,890.8587,890.8587,890.8
  筹资活动现金流出小计15,715,160.4170,321,379.2753,594,913.7731,305,805.27
  筹资活动产生的现金流量净额34,684,839.5937,578,620.7339,305,086.2327,094,194.73
四、汇率变动对现金及现金等价物的影响-5,570.36-4,869.48--
五、现金及现金等价物净增加额-1,267,764.464,719,590.84-3,574,505.4220,150,022.88
  加:期初现金及现金等价物余额30,394,424.5825,674,833.7425,674,833.7425,674,833.74
  期末现金及现金等价物余额29,126,660.1230,394,424.5822,100,328.3245,824,856.62
补充资料:
  净利润--29,853,181.08--9,022,787.72
  资产减值准备-2,540,919.07-664,313.34
  固定资产和投资性房地产折旧-27,767,014.25-13,817,864.73
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-27,767,014.25-13,817,864.73
  无形资产摊销-1,198,991.2-595,070.82
  公允价值变动损失-2,360--
  财务费用-3,442,927.7-1,376,682.4
  投资损失--22,743.28--20,383.28
  递延所得税-0--
  存货的减少--19,051,843.88--15,565,911.81
  经营性应收项目的减少-1,093,702.66-6,287,480.6
  经营性应付项目的增加-21,995,463.06-4,507,466.28
  其他--78,487.93--
  现金的期末余额-30,394,424.58-45,824,856.62
  减:现金的期初余额-25,674,833.74-25,674,833.74
  现金及现金等价物的净增加额-4,719,590.84-20,150,022.88
公告日期2026-04-272026-04-272025-10-272025-08-25
审计意见(境内)标准无保留意见
TOP↑